Innate immune memory: Implications for development of pediatric immunomodulatory agents and adjuvanted vaccines

Pediatric Research

Volumn 75, Issue 1-2, 2014, Pages 184-188

  Levy, Ofer ^a,b   Netea, Mihai G ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT; VACCINE;

BASIC RESEARCH; CHRONIC DISEASE; EPIGENETICS; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IN VITRO STUDY; IN VIVO CULTURE; INFECTION; INNATE IMMUNITY; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; COMMUNICABLE DISEASES; DRUG DESIGN; EPIGENESIS, GENETIC; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; IMMUNOLOGIC MEMORY; VACCINES;

EID: 84900389583     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.214     Document Type: Review

References (55)

1. Roitt I, Delves P, Martin SM, Burton DR. Roitt's Essential Immunology, 11th edn. Oxford, UK: Wiley, John & Sons, Inc, 2006.
2. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783-801.
3. Fearon DT. Seeking wisdom in innate immunity. Nature 1997;388:323-4.
4. Medzhitov R, Janeway CA Jr. Decoding the patterns of self and nonself by the innate immune system. Science 2002;296:298-300.
5. Kurtz J. Specific memory within innate immune systems. Trends Immunol 2005;26:186-92.
6. Faulhaber LM, Karp RD. A diphasic immune response against bacteria in the American cockroach. Immunology 1992;75:378-81.
7. Arala-Chaves M, Sequeira T. Is there any kind of adaptive immunity in invertebrates Aquaculture 2000;191:247-58.
8. Moret Y, Siva-Jothy MT. Adaptive innate immunity Responsive-mode prophylaxis in the mealworm beetle, Tenebrio molitor. Proc Biol Sci 2003;270:2475-80.
9. Rheins LA, Karp RD, Butz A. Induction of specific humoral immunity to soluble proteins in the American cockroach (Periplaneta americana). I. Nature of the primary response. Dev Comp Immunol 1980;4: 447-58.
10. Moret Y, Schmid-Hempel P. Immune defence in bumble-bee offspring. Nature 2001;414:506.
11. Witteveldt J, Cifuentes CC, Vlak JM, van Hulten MC. Protection of Penaeus monodon against white spot syndrome virus by oral vaccination. J Virol 2004;78:2057-61.
12. Netea MG, Quintin J, van der Meer JW. Trained immunity: a memory for innate host defense. Cell Host Microbe 2011;9:355-61.
13. Danilova N. The evolution of adaptive immunity. Adv Exp Med Biol 2012;738:218-35.
14. Kurtz J, Armitage SA. Alternative adaptive immunity in invertebrates. Trends Immunol 2006;27:493-6.
15. Dong Y, Taylor HE, Dimopoulos G. AgDscam, a hypervariable immunoglobulin domain-containing receptor of the Anopheles gambiae innate immune system. PLoS Biol 2006;4:e229.
16. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature 2009;457:557-61.
17. Cooper MA, Elliott JM, Keyel PA, Yang L, Carrero JA, Yokoyama WM. Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci USA 2009;106:1915-9.
18. Paust S, Senman B, von Andrian UH. Adaptive immune responses mediated by natural killer cells. Immunol Rev 2010;235:286-96.
19. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell-and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 2006;7:507-16.
20. Paust S, Gill HS, Wang BZ, et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol 2010;11:1127-35.
21. Blanden RV, Lefford MJ, Mackaness GB. The host response to Calmette-Guerin bacillus infection in mice. J Exp Med 1969;129:1079-107.
22. Sher NA, Chaparas SD, Greenberg LE, Bernard S. Effects of BCG, Corynebacterium parvum, and methanol-extration residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infections in immunosuppressed mice. Infect Immun 1975;12:1325-30.
23. Tribouley J, Tribouley-Duret J, Appriou M. [Effect of Bacillus Callmette Guerin (BCG) on the receptivity of nude mice to Schistosoma mansoni]. C R Seances Soc Biol Fil 1978;172:902-4.
24. van 't Wout JW, Poell R, van Furth R. The role of BCG/PPD-activated macrophages in resistance against systemic candidiasis in mice. Scand J Immunol 1992;36:713-9.
25. Garly ML, Martins CL, Bale C, et al. BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG Vaccine 2003;21:2782-90.
26. Rosenthal SR, Loewinsohn E, Graham ML, Liveright D, Thorne MG, Johnson V. BCG vaccination in tuberculous households. Am Rev Respir Dis 1961;84:690-704.
27. Kleinnijenhuis J, Quintin J, Preijers F, et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci USA 2012;109:17537-42.
28. Bistoni F, Vecchiarelli A, Cenci E, Puccetti P, Marconi P, Cassone A. Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect Immun 1986;51:668-74.
29. Bistoni F, Verducci G, Perito S, et al. Immunomodulation by a low-virulence, agerminative variant of Candida albicans. Further evidence for macrophage activation as one of the effector mechanisms of nonspecific anti-infectious protection. J Med Vet Mycol 1988;26:285-99.
30. Vecchiarelli A, Cenci E, Puliti M, et al. Protective immunity induced by low-virulence Candida albicans: cytokine production in the development of the anti-infectious state. Cell Immunol 1989;124:334-44.
31. Quintin J, Saeed S, Martens JH, et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 2012;12:223-32.
32. Strunk T, Prosser A, Levy O, et al. Responsiveness of human monocytes to the commensal bacterium Staphylococcus epidermidis develops late in gestation. Pediatr Res 2012;72:10-8.
33. Wynn JL, Scumpia PO, Winfield RD, et al. Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood 2008;112:1750-8.
34. Zhang JP, Yang Y, Levy O, Chen C. Human neonatal peripheral blood leukocytes demonstrate pathogen-specific coordinate expression of TLR2, TLR4/MD2, and MyD88 during bacterial infection in vivo. Pediatr Res 2010;68:479-83.
35. Kronforst KD, Mancuso CJ, Pettengill M, et al. A neonatal model of intravenous Staphylococcus epidermidis infection in mice
36. Kim YM, Romero R, Chaiworapongsa T, et al. Toll-like receptor-2 and-4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol 2004;191:1346-55.
37. Strunk T, Doherty D, Jacques A, et al. Histologic chorioamnionitis is associated with reduced risk of late-onset sepsis in preterm infants. Pediatrics 2012;129:e134-41.
38. Wynn JL, Hansen NI, Das A, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early sepsis does not increase the risk of late sepsis in very low birth weight neonates. J Pediatr 2013;162:942-8.e1-3.
39. Kleinnijenhuis J, Oosting M, Joosten LA, Netea MG, Van Crevel R. Innate immune recognition of Mycobacterium tuberculosis. Clin Dev Immunol 2011;2011:405310.
40. Aaby P, Roth A, Ravn H, et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period J Infect Dis 2011;204:245-52.
41. Miller RL, Meng TC, Tomai MA. The antiviral activity of Toll-like receptor 7 and 7/8 agonists. Drug News Perspect 2008;21:69-87.
42. Kollmann TR, Levy O, Montgomery RR, Goriely S. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 2012;37:771-83.
43. Belderbos M, Levy O, Bont L. Neonatal innate immunity in allergy development. Curr Opin Pediatr 2009;21:762-9.
44. Marrack P, McKee AS, Munks MW. Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol 2009;9:287-93.
45. Marichal T, Ohata K, Bedoret D, et al. DNA released from dying host cells mediates aluminum adjuvant activity. Nat Med 2011;17:996-1002.
46. van den Biggelaar AH, Richmond PC, Pomat WS, et al. Neonatal pneumococcal conjugate vaccine immunization primes T cells for preferential Th2 cytokine expression: a randomized controlled trial in Papua New Guinea. Vaccine 2009;27:1340-7.
47. Ritz N, Mui M, Balloch A, Curtis N. Non-specific effect of Bacille Calmette-Guerin vaccine on the immune response to routine immunisations. Vaccine 2013;31:3098-103.
48. Flanagan KL, van Crevel R, Curtis N, Shann F, Levy O; Optimmunize Network. Heterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanisms. Clin Infect Dis 2013;57:283-9.
49. van den Burg HA, Takken FL. Does chromatin remodeling mark systemic acquired resistance Trends Plant Sci 2009;14:286-94.
50. Conrath U. Molecular aspects of defence priming. Trends Plant Sci 2011;16:524-31.
51. Slaughter A, Daniel X, Flors V, Luna E, Hohn B, Mauch-Mani B. Descendants of primed Arabidopsis plants exhibit resistance to biotic stress. Plant Physiol 2012;158:835-43.
52. Durrant WE, Dong X. Systemic acquired resistance. Annu Rev Phytopathol 2004;42:185-209.
53. Jaskiewicz M, Conrath U, Peterhansel C. Chromatin modification acts as a memory for systemic acquired resistance in the plant stress response. EMBO Rep 2011;12:50-5.
54. Pham LN, Dionne MS, Shirasu-Hiza M, Schneider DS. A specific primed immune response in Drosophila is dependent on phagocytes. PLoS Pathog 2007;3:e26.
55. Rodrigues J, Brayner FA, Alves LC, Dixit R, Barillas-Mury C. Hemocyte differentiation mediates innate immune memory in Anopheles gambiae mosquitoes. Science 2010;329:1353-5.